HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inter-alpha inhibitor proteins in infants and decreased levels in neonatal sepsis.

AbstractOBJECTIVE:
Adjunctive tests are needed to predict sepsis in the newborn and to lower the rate or duration of unnecessary antibiotic use. We evaluated the normal Inter-alpha inhibitor protein (IaIp) values in infants and the association of plasma levels of IaIp with sepsis in term and preterm newborns.
METHODS:
Plasma IaIp levels were measured by enzyme-linked immunosorbent assay in samples from 135 newborn infants at a wide range of gestational ages (24-42 weeks). IaIp levels were also determined in 19 infants undergoing prospective evaluation for sepsis.
RESULTS:
IaIp levels in umbilical cord blood and circulating peripheral blood of healthy newborn infants (525+/-66 mg/L) were not significantly different from the level in healthy adults (691+/-80 mg/L). IaIp levels were similar in infants between 24 and 42 weeks gestational age. There was a significant reduction in IaIp levels in infants with sepsis compared with nonseptic controls (169+/-126 mg/L vs 613+/-286 mg/L, P<.0001).
CONCLUSIONS:
IaIp levels in the blood of newborns are independent of gestational age and similar to adults. IaIp levels are significantly reduced in infants with bacterial sepsis and might serve as an adjunctive diagnostic marker to allow prospective reduction of antibiotic use.
AuthorsYong Woon Baek, Sebastian Brokat, James F Padbury, Halit Pinar, Douglas C Hixson, Yow-Pin Lim
JournalThe Journal of pediatrics (J Pediatr) Vol. 143 Issue 1 Pg. 11-5 (Jul 2003) ISSN: 0022-3476 [Print] United States
PMID12915817 (Publication Type: Journal Article)
Chemical References
  • Alpha-Globulins
  • Anti-Bacterial Agents
  • Antibodies, Monoclonal
  • Biomarkers
  • inter-alpha-inhibitor
Topics
  • Alpha-Globulins (analysis, immunology, metabolism)
  • Anti-Bacterial Agents (therapeutic use)
  • Antibodies, Monoclonal (immunology)
  • Biomarkers
  • Candidiasis (drug therapy, microbiology)
  • Enzyme-Linked Immunosorbent Assay
  • Fetal Blood (chemistry)
  • Follow-Up Studies
  • Gestational Age
  • Humans
  • Infant, Newborn
  • Klebsiella Infections (drug therapy, microbiology)
  • Mothers
  • Prospective Studies
  • Sepsis (blood, drug therapy, microbiology)
  • Staphylococcal Infections (drug therapy, microbiology)
  • Staphylococcus epidermidis (isolation & purification)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: